Studying cytochrome P450 kinetics in drug metabolism

Bibliography

• Wrighton SA, Stevens JC. The human hepatic cytochromes P450 involved in drug metabolism. Crit Rev Toxicol 1992;22:1-21
   PubMed Web of Science ®Google Scholar
• Craig CR, Stitzel RE. Modern pharmacology with clinical applications. 6th edition. Lippincott, Williams and Wilkins, New York; 2003
   Google Scholar
• Lin JH, Lu AY. Role of pharmacokinetics and metabolism in drug discovery and development. Pharmacol Rev 1997;49:403-49
   PubMed Web of Science ®Google Scholar
• Asseffa A, Smith SJ, Nagata K, et al. Novel exogenous heme-dependent expression of mammalian cytochrome P450 using baculovirus. Arch Biochem Biophys 1989;274:481-90
   PubMed Web of Science ®Google Scholar
• Buters JT, Korzekwa KR, Kunze KL, et al. cDNA-directed expression of human cytochrome P450 CYP3A4 using baculovirus. Drug Metab Dispos 1994;22:688-92
   PubMed Web of Science ®Google Scholar
• Chernogolov A, Behlke J, Schunck WH, et al. Human CYP1A1 allelic variants: baculovirus expression and purification, hydrodynamic, spectral, and catalytical properties and their potency in the formation of all-trans-retinoic acid. Protein Expr Purif 2003;28:259-69
   PubMed Web of Science ®Google Scholar
• Ong CE, Miners JO, Birkett DJ, et al. Baculovirus-mediated expression of cytochrome P4502C8 and human NADPH-cytochrome P450 reductase: optimization of protein expression. N Engl J Med 1998;28:137-52
   Google Scholar
• Chen L, Buters JT, Hardwick JP, et al. Coexpression of cytochrome P4502A6 and human NADPH-P450 oxidoreductase in the baculovirus system. Drug Metab Dispos 1997;25:399-405
   PubMed Web of Science ®Google Scholar
• McGinnity DF, Griffin SJ, Moody GC, et al. Rapid characterization of the major drug-metabolizing human hepatic cytochrome P-450 enzymes expressed in Escherichia coli. Drug Metab Dispos 1999;27:1017-23
   PubMed Web of Science ®Google Scholar
• Raucy JL, Lasker JM. Isolation of P450 enzymes from human liver. Methods Enzymol 1991;206:577-87
   PubMed Web of Science ®Google Scholar
• Pearce RE, McIntyre CJ, Madan A, et al. Effects of freezing, thawing, and storing human liver microsomes on cytochrome P450 activity. Arch Biochem Biophys 1996;331:145-69
   PubMed Web of Science ®Google Scholar
• Yamazaki H, Inoue K, Turvy CG, et al. Effects of freezing, thawing, and storage of human liver samples on the microsomal contents and activities of cytochrome p450 enzymes. Drug Metab Dispos 1997;25:168-74
   PubMed Web of Science ®Google Scholar
• Gomez-Lechon MJ, Donato MT, Castell JV, et al. Human hepatocytes in primary culture: the choice to investigate drug metabolism in man. Curr Drug Metab 2004;5:443-62
   PubMed Web of Science ®Google Scholar
• Nelson AC, Huang W, Moody DE. Variables in human liver microsome preparation: impact on the kinetics of l-alpha-acetylmethadol (LAAM) n-demethylation and dextromethorphan O-demethylation. Drug Metab Dispos 2001;29:319-25
   PubMed Web of Science ®Google Scholar
• Nakamura K, Ariyoshi N, Yokoi T, et al. CYP2D6.10 present in human liver microsomes shows low catalytic activity and thermal stability. Biochem Biophys Res Commun 2002;293:969-73
   PubMed Web of Science ®Google Scholar
• Parkinson A, Mudra DR, Johnson C, et al. The effects of gender, age, ethnicity, and liver cirrhosis on cytochrome P450 enzyme activity in human liver microsomes and inducibility in cultured human hepatocytes. Toxicol Appl Pharmacol 2004;199:193-209
   PubMed Web of Science ®Google Scholar
• Patki KC, von Moltke LL, Harmatz JS, et al. Effect of age on in vitro triazolam biotransformation in male human liver microsomes. J Pharmacol Exp Ther 2004;308:874-9
   PubMed Web of Science ®Google Scholar
• Brandon EF, Raap CD, Meijerman I, et al. An update on in vitro test methods in human hepatic drug biotransformation research: pros and cons. Toxicol Appl Pharmacol 2003;189:233-46
   PubMed Web of Science ®Google Scholar
• Olinga P, Merema M, Hof IH, et al. Effect of human liver source on the functionality of isolated hepatocytes and liver slices. Drug Metab Dispos 1998;26:5-11
   PubMed Web of Science ®Google Scholar
• Olinga P, Merema MT, Hof IH, et al. Effect of cold and warm ischaemia on drug metabolism in isolated hepatocytes and slices from human and monkey liver. N Engl J Med 1998;28:349-60
   Google Scholar
• Gomez-Lechon MJ, Lahoz A, Jimenez N, et al. Cryopreservation of rat, dog and human hepatocytes: influence of preculture and cryoprotectants on recovery, cytochrome P450 activities and induction upon thawing. N Engl J Med 2006;36:457-72
   Google Scholar
• Hewitt NJ, Buhring KU, Dasenbrock J, et al. Studies comparing in vivo:in vitro metabolism of three pharmaceutical compounds in rat, dog, monkey, and human using cryopreserved hepatocytes, microsomes, and collagen gel immobilized hepatocyte cultures. Drug Metab Dispos 2001;29:1042-50
   PubMed Web of Science ®Google Scholar
• Hewitt NJ, Fischer T, Zuehlke U, et al. Metabolic activity of fresh and cryopreserved cynomolgus monkey (Macaca fascicularis) hepatocytes. N Engl J Med 2000;30:665-81
   Google Scholar
• McGinnity DF, Soars MG, Urbanowicz RA, et al. Evaluation of fresh and cryopreserved hepatocytes as in vitro drug metabolism tools for the prediction of metabolic clearance. Drug Metab Dispos 2004;32:1247-53
   PubMed Web of Science ®Google Scholar
• Garcia M, Rager J, Wang Q, et al. Cryopreserved human hepatocytes as alternative in vitro model for cytochrome p450 induction studies. in vitro Cell Dev Biol Anim 2003;39:283-7
   PubMed Web of Science ®Google Scholar
• Roymans D, Annaert P, Van HJ, et al. Expression and induction potential of cytochromes P450 in human cryopreserved hepatocytes. Drug Metab Dispos 2005;33:1004-16
   PubMed Web of Science ®Google Scholar
• Rodriguez-Antona C, Donato MT, Boobis A, et al. Cytochrome P450 expression in human hepatocytes and hepatoma cell lines: molecular mechanisms that determine lower expression in cultured cells. N Engl J Med 2002;32:505-20
   Google Scholar
• Wilkening S, Bader A. Influence of culture time on the expression of drug-metabolizing enzymes in primary human hepatocytes and hepatoma cell line HepG2. J Biochem Mol Toxicol 2003;17:207-13
   PubMed Web of Science ®Google Scholar
• Binda D, Lasserre-Bigot D, Bonet A, et al. Time course of cytochromes P450 decline during rat hepatocyte isolation and culture: effect of L-NAME. Toxicol in vitro 2003;17:59-67
   PubMed Web of Science ®Google Scholar
• Guillouzo A, Morel F, Fardel O, et al. Use of human hepatocyte cultures for drug metabolism studies. Toxicology 1993;82:209-19
   PubMed Web of Science ®Google Scholar
• Auth MK, Woitaschek D, Beste M, et al. Preservation of the synthetic and metabolic capacity of isolated human hepatocytes by coculture with human biliary epithelial cells. Liver Transpl 2005;11:410-9
   PubMed Web of Science ®Google Scholar
• Nahmias Y, Kramvis Y, Barbe L, et al. A novel formulation of oxygen-carrying matrix enhances liver-specific function of cultured hepatocytes. FASEB J 2006;20:2531-3
   PubMed Web of Science ®Google Scholar
• Wang YJ, Liu HL, Guo HT, et al. Primary hepatocyte culture in collagen gel mixture and collagen sandwich. World J Gastroenterol 2004;10:699-702
   PubMed Web of Science ®Google Scholar
• Miyamoto Y, Suzuki S, Nomura K, et al. Improvement of hepatocyte viability after cryopreservation by supplementation of long-chain oligosaccharide in the freezing medium in rats and humans. Cell Transplant 2006;15:911-9
   PubMed Web of Science ®Google Scholar
• Lerche-Langrand C, Toutain HJ. Precision-cut liver slices: characteristics and use for in vitro pharmaco-toxicology. Toxicology 2000;153:221-53
   PubMed Web of Science ®Google Scholar
• Guillouzo A, Morel F, Ratanasavanh D, et al. Long term culture of functional hepatocytes. Toxicol in vitro 1990;4:415-27
   PubMed Web of Science ®Google Scholar
• Fisher RL, Gandolfi AJ, Brendel K. Human liver quality is a dominant factor in the outcome of in vitro studies. Cell Biol Toxicol 2001;17:179-89
   PubMed Web of Science ®Google Scholar
• Vickers AE, Fisher RL. Organ slices for the evaluation of human drug toxicity. Chem Biol Interact 2004;150:87-96
   PubMed Web of Science ®Google Scholar
• Vandenbranden M, Wrighton SA, Ekins S, et al. Alterations of the catalytic activities of drug-metabolizing enzymes in cultures of human liver slices. Drug Metab Dispos 1998;26:1063-8
   PubMed Web of Science ®Google Scholar
• de Kanter R, de Jager MH, Draaisma AL, et al. Drug-metabolizing activity of human and rat liver, lung, kidney and intestine slices. Xenobiotica 2002;32:349-62
   PubMed Web of Science ®Google Scholar
• MacGregor JT, Collins JM, Sugiyama Y, et al. in vitro human tissue models in risk assessment: report of a consensus-building workshop. Toxicol Sci 2001;59:17-36
   PubMedGoogle Scholar
• Hashemi E, Till C, Ioannides C. Stability of cytochrome P450 proteins in cultured precision-cut rat liver slices. Toxicology 2000;149:51-61
   PubMed Web of Science ®Google Scholar
• Renwick AB, Watts PS, Edwards RJ, et al. Differential maintenance of cytochrome P450 enzymes in cultured precision-cut human liver slices. Drug Metab Dispos 2000;28:1202-9
   PubMed Web of Science ®Google Scholar
• Hutzler JM, Wienkers LC, Wahlstrom JL, et al. Activation of cytochrome P450 2C9-mediated metabolism: mechanistic evidence in support of kinetic observations. Arch Biochem Biophys 2003;410:16-24
   PubMed Web of Science ®Google Scholar
• Dabrowski MJ, Schrag ML, Wienkers LC, et al. Pyrene.pyrene complexes at the active site of cytochrome P450 3A4: evidence for a multiple substrate binding site. J Am Chem Soc 2002;124:11866-7
   PubMed Web of Science ®Google Scholar
• Rock DA, Perkins BN, Wahlstrom J, et al. A method for determining two substrates binding in the same active site of cytochrome P450BM3: an explanation of high energy omega product formation. Arch Biochem Biophys 2003;416:9-16
   PubMed Web of Science ®Google Scholar
• Hummel MA, Gannett PM, Aguilar JS, et al. Effector-mediated alteration of substrate orientation in cytochrome P450 2C9. Biochemistry 2004;43:7207-14
   PubMed Web of Science ®Google Scholar
• Hutzler JM, Tracy TS. Atypical kinetic profiles in drug metabolism reactions. Drug Metab Dispos 2002;30:355-62
   PubMed Web of Science ®Google Scholar
• Shou M, Mei Q, Ettore MW Jr, et al. Sigmoidal kinetic model for two co-operative substrate-binding sites in a cytochrome P450 3A4 active site: an example of the metabolism of diazepam and its derivatives. Biochem J 1999;340:845-53
   PubMed Web of Science ®Google Scholar
• Korzekwa KR, Krishnamachary N, Shou M, et al. Evaluation of atypical cytochrome P450 kinetics with two- substrate models: evidence that multiple substrates can simultaneously bind to cytochrome P450 active sites. Biochemistry 1998;37:4137-47
   PubMed Web of Science ®Google Scholar
• Lin Y, Lu P, Tang C, et al. Substrate inhibition kinetics for cytochrome P450-catalyzed reactions. Drug Metab Dispos 2001;29:368-74
   PubMed Web of Science ®Google Scholar
• Shou M, Grogan J, Mancewicz JA, et al. Activation of CYP3A4: evidence for the simultaneous binding of two substrates in a cytochrome P450 active site. Biochemistry 1994;33:6450-5
   PubMed Web of Science ®Google Scholar
• Egnell AC, Houston JB, Boyer CS. in vivo CYP3A4 heteroactivation is a possible mechanism for the drug interaction between felbamate and carbamazepine. J Pharmacol Exp Ther 2003;305:1251-62
   Google Scholar
• Hummel MA, Dickmann LJ, Rettie AE, et al. Differential activation of CYP2C9 variants by dapsone. Biochem Pharmacol 2004;67:1831-41
   PubMed Web of Science ®Google Scholar
• Yao C, Levy RH. Inhibition-based metabolic drug–drug interactions: predictions from in vitro data. J Pharm Sci 2002;91:1923-35
   PubMed Web of Science ®Google Scholar
• Hermann M, Kase ET, Molden E, et al. Evaluation of microsomal incubation conditions on CYP3A4-mediated metabolism of cyclosporine A by a statistical experimental design. Curr Drug Metab 2006;7:265-71
   PubMed Web of Science ®Google Scholar
• Yamazaki H, Ueng YF, Shimada T, et al. Roles of divalent metal ions in oxidations catalyzed by recombinant cytochrome P450 3A4 and replacement of NADPH: cytochrome P450 reductase with other flavoproteins, ferredoxin, and oxygen surrogates. Biochemistry 1995;34:8380-9
   PubMed Web of Science ®Google Scholar
• Shet MS, Fisher CW, Holmans PL, et al. Human cytochrome-P450-3A4-enzymatic properties of a purified recombinant fusion protein containing NADPH-P450 reductase. Proc Natl Acad Sci USA 1993;90:11748-52
   PubMed Web of Science ®Google Scholar
• Bjornsson TD, Callaghan JT, Einolf HJ, et al. The conduct of in vitro and in vivo drug–drug interaction studies: a Pharm. Res. and Manufacturers of America (PhRMA) perspective. Drug Metab Dispos 2003;31:815-32
   PubMed Web of Science ®Google Scholar
• Tucker GT, Houston JB, Huang SM. Optimizing drug development: strategies to assess drug metabolism/transporter interaction potential: towards a consensus. Br J Clin Pharmacol 2001;52:107-17
   PubMed Web of Science ®Google Scholar
• Busby WF Jr, Ackermann JM, Crespi CL. Effect of methanol, ethanol, dimethyl sulfoxide, and acetonitrile on in vitro activities of cDNA-expressed human cytochromes P-450. Drug Metab Dispos 1999;27:246-9
   PubMed Web of Science ®Google Scholar
• Tang C, Shou M, Rodrigues AD. Substrate-dependent effect of acetonitrile on human liver microsomal cytochrome P450 2C9 (CYP2C9) activity. Drug Metab Dispos 2000;28:567-72
   PubMed Web of Science ®Google Scholar
• Vuppugalla R, Chang SY, Zhang H, et al. Effect of commonly used organic solvents on the kinetics of cytochrome P450 2B6- and 2C8-dependent activity in human liver microsomes. Drug Metab Dispos 2007;35:1990-5
   PubMed Web of Science ®Google Scholar
• Easterbrook J, Lu C, Sakai Y, et al. Effects of organic solvents on the activities of cytochrome P450 isoforms, UDP-dependent glucuronyl transferase, and phenol sulfotransferase in human hepatocytes. Drug Metab Dispos 2001;29:141-4
   PubMed Web of Science ®Google Scholar
• Chauret N, Gauthier A, Nicollgriffith DA. Effect of common organic solvents on in vitro cytochrome P450-mediated metabolic activities in human liver microsomes. Drug Metab Dispos 1998;26:1-4
   PubMed Web of Science ®Google Scholar
• Hickman D, Wang JP, Wang Y, et al. Evaluation of the selectivity of in vitro probes and suitability of organic solvents for the measurement of human cytochrome P450 monooxygenase activities. Drug Metab Dispos 1998;26:207-15
   PubMed Web of Science ®Google Scholar
• Cotreau-Bibbo MM, von Moltke LL, Greenblatt DJ. Influence of polyethylene glycol and acetone on the in vitro biotransformation of tamoxifen and alprazolam by human liver microsomes. J Pharm Sci 1996;85:1180-5
   PubMed Web of Science ®Google Scholar
• Palamanda J, Feng WW, Lin CC, et al. Stimulation of tolbutamide hydroxylation by acetone and acetonitrile in human liver microsomes and in a cytochrome P-450 2C9-reconstituted system. Drug Metab Dispos 2000;28:38-43
   PubMed Web of Science ®Google Scholar
• Austin RP, Barton P, Cockroft SL, et al. The influence of nonspecific microsomal binding on apparent intrinsic clearance, and its prediction from physicochemical properties. Drug Metab Dispos 2002;30:1497-503
   PubMed Web of Science ®Google Scholar
• McLure JA, Miners JO, Birkett DJ. Nonspecific binding of drugs to human liver microsomes. Br J Clin Pharmacol 2000;49:453-61
   PubMed Web of Science ®Google Scholar
• Obach RS. Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: An examination of in vitro half- life approach and nonspecific binding to microsomes. Drug Metab Dispos 1999;27:1350-9
   PubMed Web of Science ®Google Scholar
• Venkatakrishnan K, von Moltke LL, Obach RS, et al. Microsomal binding of amitriptyline: effect on estimation of enzyme kinetic parameters in vitro. J Pharmacol Exp Ther 2000;293:343-50
   PubMed Web of Science ®Google Scholar
• Carlile DJ, Zomorodi K, Houston JB. Scaling factors to relate drug metabolic clearance in hepatic microsomes, isolated hepatocytes, and the intact liver: studies with induced livers involving diazepam. Drug Metab Dispos 1997;25:903-11
   PubMed Web of Science ®Google Scholar
• Tang C, Lin Y, Rodrigues AD, et al. Effect of albumin on phenytoin and tolbutamide metabolism in human liver microsomes: an impact more than protein binding. Drug Metab Dispos 2002;30:648-54
   PubMed Web of Science ®Google Scholar